Feb 7th 2023 - Mar 21st 2023
Missling is being "patient" taking month... See more
Abrahams sees ultimate approval as "very like... See more
Feb 7th 2023 - Mar 21st 2023
$TGTX next few weeks will be a good buying opportu... See more
$TGTX "4 Stories of Living with Multiple Scle... See more
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$INTC " Industry is responding well to Found... See more
$INTC I really would like to meet some of the shor... See more
Missling is being "patient" taking months longer than any other company to analyze and release trial data (and then not actually releasing the full data set), so he's awesome.
Abrahams sees ultimate approval as "very likely" and a favorable setup in Biogen shares.
$AVXL George Perry stated, the Anavex drug is "revolutionary", as is uniquely good, no other drug has EVER increased cognition EVER.
IMO, with their "rapid" label and test showing sustained improvement in cognition and daily living, it will be hard not to try Auvelity if you suffer from MDD.
Value is what you get. "Revolutionary."
The results are incredible and 50mg study with no side effects is spectacular."
The information points clearly this is much better than "Aduhelm" or Lecanemab.
$TGTX next few weeks will be a good buying opportunity for "risk on" assets imo.
$TGTX "4 Stories of Living with Multiple Sclerosis" Briumvi, the best and most affordable, 1HR infusion, no black box label warning, and no warning or report of causing breast cancer.
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Check it out below.""" 👇 Highly recommend everyone to follow them 💪 https://amazing-stocks-us.stockmarketus.net/
$INTC " Industry is responding well to Foundry approach and we're seeing strong momentum.
$INTC I really would like to meet some of the shorts in here, I would happily spend a night in the "clink" to punch one right in the stupid f***** lips.
Completely mind blowing that Intel can actually "compete" with team red and green in mid level gaming.
$INTC Damn "Stuff4less92" Impressive Viewpoint!
Been following Jamie D. for many years and honestly believe his analyses are " top shelf".
$AMD GENOA chips look awesome, especially compared to "hot" $INTC 12th gen CPUs.
$INTC Wall Street's like: "Because Reasons" And I'm like Buy!
I truly look forward to sharing those successes with you in the future."
